The present invention relates to drug mixing systems generally and particularly to a safety feature that prevents rapid and sudden separation of a fluid flow adapter element from the syringe adapter element
Drug mixing systems are well known in the art. One particular drug mixing system is described in published PCT patent application WO 2005/041846, assigned to the current assignee of the present application, the disclosure of which is incorporated herein by reference. The drug mixing system is commercially available from Teva Medical Ltd. and is sold under the brand name Tevadaptor. It is a system for safe compounding and administration of hazardous intravenous drugs. Tevadaptor minimizes the risk of exposure to hazardous drug substances, and eliminates the risk of needle stick injuries. The drug mixing system is intended for use with a luer fitted hypodermic syringe, and is particularly useful for handling toxic drugs such as antineoplastic drugs.
The Tevadaptor drug mixing system includes a receptacle port adapter that can be inserted into a port of a fluid receptacle, such as an IV bag. A vial adapter element is provided for connection to a vial containing a drug. A syringe adapter element may be attached to a syringe and to the receptacle port adapter and/or the vial adapter element. The receptacle port adapter, syringe adapter element and/or the vial adapter element may be vented to the atmosphere in a manner that prevents release to the atmosphere of possibly harmful contents of the vial in a liquid, solid or gaseous form.
The syringe adapter element may have a needle that fluidly communicates with the contents of the syringe. The needle does not normally protrude outwards, but rather is sealed inside the syringe adapter element by a septum. The syringe adapter element may be screwed onto the luer lock tip of the syringe. The needle of the syringe adapter element is now in fluid communication with the contents of the syringe.
Similarly, the vial adapter element may have a spike that fluidly communicates with the contents of the vial, and is sealed by a septum. The vial may be pushed onto the vial adapter element, wherein the spike of the vial adapter element punctures the septum of the vial. The vial adapter element may then be pushed onto the syringe adapter element, wherein the needle of the syringe adapter element punctures the septa of the syringe adapter element and the vial adapter assembly. This allows fluid to flow from the syringe through the needle of the syringe adapter element and through the spike of the vial adapter element to the vial.
After filling the vial with a desired amount of fluid, the vial adapter assembly may be separated from the syringe adapter element. Immediately upon separation, the needle of the syringe adapter element retracts inwards and is sealed by elastomeric septa. In this manner, no fluid drips outwards.
The present invention seeks to provide further features to a drug mixing system, particularly a further safety feature that prevents premature separation of a fluid flow adapter septum element from the syringe adapter septum element. This safety feature may further ensure that no fluid drips outward when separating these parts from one another.
There is thus provided in accordance with an embodiment of the present invention a syringe adapter element for use in a drug mixing system including a housing element having a syringe port adapted for fluid connection with a syringe and a fluid port adapted for fluid connection with a fluid flow adapter element, a needle and at least one septum disposed in the housing element, the needle having a sealed orientation wherein the at least one septum blocks fluid flow through the needle, and a fluid flow orientation wherein the needle punctures the at least one septum so as to permit fluid to flow through the needle, and an anti-separation device adjacent the fluid port, such that when the syringe adapter element is connected to a fluid flow adapter element, the anti-separation device applies a force that acts against separating the syringe adapter septum element from the fluid flow adapter septum element.
In accordance with an embodiment of the present invention the anti-separation device includes a ring member with a plurality of resilient leaves disposed inside a keeper element, the keeper element having a first bore sized to prevent outward expansion of the resilient leaves and a second bore, larger than the first bore, sized to permit outward expansion of the resilient leaves, the resilient leaves being adapted to resiliently fasten onto a fluid flow adapter element, the anti-separation device having first and second positions, wherein in the first position, the resilient leaves are positioned in the first bore and are adapted to hold onto the fluid flow adapter element, and in the second position, the resilient leaves are positioned in the second bore and are adapted to expand outward to release the fluid flow adapter element.
In accordance with another embodiment of the present invention the anti-separation device includes a plurality of inwardly facing protrusions formed on an inner perimeter of the fluid port adapted to apply a friction force against a fluid flow adapter element inserted in the fluid port.
In accordance with yet another embodiment of the present invention the anti-separation device includes at least one non-straight channel formed in one of the fluid flow adapter elements that interfaces with a tooth formed in the other of the syringe adapter and fluid flow adapter elements, wherein a axial force applied to separate the syringe adapter and fluid flow adapter elements is acted against by the tooth moving in the non-straight channel.
The present invention will be understood and appreciated more fully from the following detailed description, taken in conjunction with the drawings in which:
Reference is now made to
The drug mixing system may include a luer fitted hypodermic syringe 40 having a plunger 42 and a luer tip 44, which can be attached to a syringe port 15 of a syringe adapter element 50.
Syringe adapter element 50 may include a housing element 500, which has seated therein a forward septum 502 and a rearward septum 504 in an intermediate portion 514. Syringe adapter element 50 may include a body 524 in which a spring 536 and needle 550 are disposed. Extending from body 524 are outwardly protruding arms 526, defining at an inner facing forward end thereof teeth 527 having transversely extending rearward facing surfaces 528 which engage with intermediate portion 514. Needle 550 may extend axially within compression spring 536 and through the center of axially movable housing element 500 and rearward septum 504. A sharpened tip of needle 550 may be placed between forward septum 502 and rearward septum 504, thus maintaining the needle inaccessible to a user and to the atmosphere.
The drug mixing system allows connecting syringe adapter element 50 to different adapter elements, such as but not limited to, a vial adapter element 30, a spike port adapter element (not shown) or needle port adapter element (also not shown). For example, connecting syringe adapter element 50 to either the spike port adapter element or the needle port adapter element permits fluid to flow through the spike port adapter element or through the needle port adapter element directly into syringe 40 via the syringe adapter element 50. This ensures that the fluid remains sterile, and that the user is not exposed to the fluid. Subsequently, the syringe 40 and syringe adapter element 50 may be disconnected from the spike port adapter element or the needle port adapter element. The drug mixing system ensures that the user is not exposed to the fluid during disconnection thereof.
The present invention will be described with particular reference to connection between the syringe adapter element 50 and the vial adapter element 30, but it is appreciated that the invention is applicable for connection of the syringe adapter element 50 to any of the abovementioned adapter elements. These adapter elements will be referred to alternatively in the specification and claims as fluid flow adapter elements.
As seen in
The vial adapter element 30 may include a hollow vial puncturing spike 322 that extends (
The user may simply push the vial adapter assembly 30 in the direction of the arrow in
The user may then turn the drug mixing system upside down and retract plunger 42, thus drawing at least part of the solution from the vial 10 into syringe 40. Subsequently, syringe 40 and syringe adapter element 50 may be disconnected. Septa 350 and 502 remain in touching relationship, while housing element 500 moves forward under action of the spring 536, until the needle tip returns to its resting position inside housing 500, thus preventing liquid spill.
As mentioned before, in accordance with embodiments of the present invention, a safety feature is provided that prevents exposure of the needle tip before the respective septa of the syringe adapter and fluid flow element have separated from each other. This safety feature may further ensure that no fluid drips outward when separating these parts from one another.
Reference is now made to
As similarly described hereinabove for syringe adapter element 50 (like elements being designated by like numerals), syringe adapter element 200 may include housing element 500 having syringe port 15 adapted for fluid connection with syringe 40 (15 and 40 not shown in
In accordance with an embodiment of the present invention, an anti-separation device 206 is adjacent fluid port 202. As will be described hereinbelow, when syringe adapter element 200 is connected to fluid flow adapter element 204, the anti-separation device 206 temporarily connects housing 500 to fluid flow element 204.
In the non-limiting illustrated embodiment, the anti-separation device 206 includes a ring member 208 with a plurality of resilient leaves 210 disposed inside a keeper element 212. Keeper element 212 (which is part of the syringe adapter) has a first bore 214 sized to prevent outward expansion of the resilient leaves 210 and a second bore 216, larger than the first bore 214, sized to permit outward expansion of the resilient leaves 210.
Referring now to
It is noted that in the first position, needle 550 can pierce septum 502, whereas in the second position, needle 550 cannot pierce septum 502.
Reference is now made to
Reference is now made to
It is appreciated that various features of the invention which are, for clarity, described in the contexts of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination.
Number | Name | Date | Kind |
---|---|---|---|
6478788 | Aneas | Nov 2002 | B1 |
6571837 | Jansen et al. | Jun 2003 | B2 |
6706031 | Manera | Mar 2004 | B2 |
20050203481 | Orlu et al. | Sep 2005 | A1 |
Number | Date | Country | |
---|---|---|---|
20080097371 A1 | Apr 2008 | US |